PND68 COST-EFFECTIVENESS OF OCRELIZUMAB COMPARED TO FINGOLIMOD OR DMF IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CZECH REPUBLIC
May 1, 2019, 00:00
10.1016/j.jval.2019.04.1341
https://www.valueinhealthjournal.com/article/S1098-3015(19)31533-5/fulltext
Title :
PND68 COST-EFFECTIVENESS OF OCRELIZUMAB COMPARED TO FINGOLIMOD OR DMF IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CZECH REPUBLIC
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31533-5&doi=10.1016/j.jval.2019.04.1341
First page :
Section Title :
Open access? :
No
Section Order :
10838